| Market Cap | 8.76B | P/E | 23.16 | EPS this Y | - | Ern Qtrly Grth | 75.90% |
| Income | 51.01B | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -15.00% |
| Sales | 503.08B | PEG | - | EPS past 5Y | - | 200D Avg Chg | -18.00% |
| Dividend | 332.00% | Price/Book | 0.02 | EPS next 5Y | - | 52W High Chg | -29.00% |
| Recommedations | - | Quick Ratio | 2.17 | Shares Outstanding | 606.28M | 52W Low Chg | 1.00% |
| Insider Own | - | ROA | 5.01% | Shares Float | 287.77M | Beta | -0.04 |
| Inst Own | - | ROE | 10.05% | Shares Shorted/Prior | -/- | Price | 27.09 |
| Gross Margin | 59.62% | Profit Margin | 10.14% | Avg. Volume | 1,219 | Target Price | - |
| Oper. Margin | 6.50% | Earnings Date | Jul 26 | Volume | 75 | Change | 0.00% |
Yakult Honsha Co.,Ltd. manufactures and sells food and beverage products in Japan, the Americas, Asia, Oceania, and Europe. The company operates through Food and Beverages (Japan), Food and Beverages (The Americas), Food and Beverages (Asia and Oceania), Food and Beverages (Europe), Pharmaceuticals, and Others segments. It offers fermented milk drinks, juices, noodles, etc. through its home delivery and retail store channels. The company also provides pharmaceutical products, such as Elplat, an antineoplastic drug, as well as anticancer drugs and other pharmaceuticals. In addition, it offers cosmetics; and operates the Tokyo Yakult Swallows, a professional baseball team. The company was founded in 1935 and is headquartered in Tokyo, Japan.